CMPK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.657000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.372200E-01
Normal-vs-Stage2
7.794000E-01
Normal-vs-Stage3
8.547000E-01
Normal-vs-Stage4
2.596600E-01
Stage1-vs-Stage2
7.719000E-01
Stage1-vs-Stage3
6.135400E-01
Stage1-vs-Stage4
5.926400E-01
Stage2-vs-Stage3
5.106600E-01
Stage2-vs-Stage4
1.187970E-01
Stage3-vs-Stage4
2.507600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.136800E-01
Normal-vs-AfricanAmerican
5.971600E-01
Normal-vs-Asian
6.659200E-01
Caucasian-vs-AfricanAmerican
4.517200E-01
Caucasian-vs-Asian
4.720600E-01
AfricanAmerican-vs-Asian
9.557400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.063400E-01
Normal-vs-Female
8.193400E-01
Male-vs-Female
6.150200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.515400E-01
Normal-vs-Age(41-60Yrs)
6.533200E-01
Normal-vs-Age(61-80Yrs)
9.252600E-01
Normal-vs-Age(81-100Yrs)
9.951400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.110200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.361600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.424200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.030200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.290800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.666200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.411800E-01
Normal-vs-Daily Drinker
9.590000E-01
Normal-vs-Weekly Drinker
5.445000E-01
Normal-vs-Occasional Drinker
7.286800E-01
Normal-vs-Social Drinker
9.092200E-01
Non Drinker-vs-Daily Drinker
7.958400E-01
Non Drinker-vs-Weekly Drinker
1.626250E-01
Non Drinker-vs-Occasional Drinker
7.134200E-01
Non Drinker-vs-Social Drinker
5.528800E-01
Daily Drinker-vs-Weekly Drinker
3.531800E-01
Daily Drinker-vs-Occasional Drinker
6.041200E-01
Daily Drinker-vs-Social Drinker
7.955000E-01
Weekly Drinker-vs-Occasional Drinker
1.280250E-01
Weekly Drinker-vs-Social Drinker
3.804400E-01
Occasional Drinker-vs-Social Drinker
3.946800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.270040E-01
Normal-vs-Grade 2
1.861740E-02
Normal-vs-Grade 3
1.875540E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.060900E-03
Grade 1-vs-Grade 3
7.880100E-02
Grade 1-vs-Grade 4
1.270040E-01
Grade 2-vs-Grade 3
8.505700E-02
Grade 2-vs-Grade 4
1.861740E-02
Grade 3-vs-Grade 4
1.875540E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.606800E-01
Normal-vs-NonDiabetic
8.938200E-01
Diabetic-vs-NonDiabetic
3.338400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.966200E-01
Normal-vs-NoPancreatitis
9.525600E-01
Pancreatitis-vs-NoPancreatitis
4.135400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.210200E-01
Normal-vs-N1
8.210800E-01
N0-vs-N1
8.496000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.884200E-01
Normal-vs-TP53-NonMutant
7.755400E-01
TP53-Mutant-vs-TP53-NonMutant
7.424000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
